首页> 美国卫生研究院文献>other >Characterization of Desmoglein Expression in the Normal Prostatic Gland. Desmoglein 2 Is an Independent Prognostic Factor for Aggressive Prostate Cancer
【2h】

Characterization of Desmoglein Expression in the Normal Prostatic Gland. Desmoglein 2 Is an Independent Prognostic Factor for Aggressive Prostate Cancer

机译:正常前列腺中桥粒芯蛋白表达的表征。 Desmoglein 2是侵略性前列腺癌的独立预后因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeThe expression of desmogleins (DSGs), which are known to be crucial for establishing and maintaining the cell-cell adhesion required for tissue integrity, has been well characterized in the epidermis and hair follicle; however, their expression in other epithelial tissues such as prostate is poorly understood. Although downregulation of classical cadherins, such as E-cadherin, has been described in prostate cancer tissue samples, the expression of desmogleins has only been previously reported in prostate cancer cell lines. In this study we characterized desmoglein expression in normal prostate tissues, and further investigated whether Desmoglein 2 (DSG2) expression specifically can serve as a potential clinical prognostic factor for patients diagnosed with primary prostate cancer.
机译:目的在表皮和毛囊中已经充分表征了桥粒芯糖蛋白(DSG)的表达,对于建立和维持组织完整性所需的细胞粘附至关重要。然而,它们在诸如前列腺的其他上皮组织中的表达却知之甚少。尽管已经在前列腺癌组织样品中描述了经典钙粘蛋白例如E-钙粘蛋白的下调,但是桥粒糖蛋白的表达以前仅在前列腺癌细胞系中被报道。在这项研究中,我们表征了desmoglein在正常前列腺组织中的表达,并进一步研究了Desmoglein 2(DSG2)表达是否特别可以作为诊断为原发性前列腺癌的患者的潜在临床预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号